• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Dow Falls Over 50 Points; US Small Business Optimism Surges In June

    7/9/24 9:42:27 AM ET
    $HELE
    $INDV
    $PEGY
    $QURE
    Home Furnishings
    Consumer Discretionary
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $HELE alert in real time by email

    U.S. stocks traded mixed this morning, with the Dow Jones index falling more than 50 points on Tuesday.

    Following the market opening Tuesday, The Dow traded down 0.15% to 39,285.05 while the NASDAQ rose 0.46% to 18,489.15. The S&P 500 also rose, gaining, 0.22% to 5,585.27.

    Check This Out: Nvidia To Rally Over 40%? Here Are 10 Top Analyst Forecasts For Tuesday

    Leading and Lagging Sectors

    Communication services shares jumped by 0.9% on Tuesday.

    In trading on Tuesday, energy shares fell by 1.2%.

    Top Headline

    The NFIB Small Business Optimism Index increased to 91.5 in June from 90.5 in May, recording the strongest reading since the start of the year.

    Equities Trading UP
                           

    • Soligenix, Inc. (NASDAQ:SNGX) shares shot up 193% to $5.86 after the company announced interim results for extended HyBryte treatment in early-stage CTCL patients.
    • Shares of Pineapple Energy Inc. (NASDAQ:PEGY) got a boost, surging 54% to $1.85 after the company engaged Conduit Capital to provide structural internal support, staffing, and assistance with capital-raising activities.
    • uniQure N.V. (NASDAQ:QURE) shares were also up, gaining 41% to $5.31 after the company announced updated interim data including up to 24 months of follow-up data from 29 treated patients enrolled in the ongoing U.S. and European Phase I/II clinical trials of AMT-130 for the treatment of Huntington’s disease.

    Equities Trading DOWN

    • Indivior PLC (NASDAQ:INDV) shares dropped 35% to $9.91 after the company lowered its FY24 guidance.
    • Shares of Helen of Troy Limited (NASDAQ:HELE) were down 31% to $61.30 after the company reported soft first-quarter earnings and lowered its FY25 guidance.
    • Shapeways Holdings, Inc. (NASDAQ:SHPW) was down, falling 26% to $0.3613 after jumping 132% on Monday.

    Also Check This Out: How To Earn $500 A Month From PepsiCo Stock Ahead Of Q2 Earnings Report

    Commodities

    In commodity news, oil traded down 0.4% to $82.01 while gold traded up 0.2% at $2,367.50.

    Silver traded up 1.3% to $31.31 on Tuesday, while copper fell 0.1% to $4.6145.

    Euro zone

    European shares were lower today. The eurozone's STOXX 600 fell 0.4%, Germany's DAX fell 0.5% and France's CAC 40 fell 1%. Spain's IBEX 35 Index declined 0.8%, while London's FTSE 100 fell 0.3%.

    Asia Pacific Markets

    Asian markets closed mostly higher on Tuesday, with Japan's Nikkei gaining 1.96%, Hong Kong's Hang Seng Index declining 0.01%, China's Shanghai Composite Index climbing 1.26% and India's S&P BSE Sensex gaining 0.49%.

    Japanese machine tool orders climbed by 9.7% year-over-year to JPY 133,817 million in June compared to a 4.2% rise in the prior month.

    Economics

    The NFIB Small Business Optimism Index increased to 91.5 in June from 90.5 in May, recording the strongest reading since the start of the year.

    Now Read This: Qualcomm, Robinhood And 2 Other Stocks Insiders Are Selling

    Get the next $HELE alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $HELE
    $INDV
    $PEGY
    $QURE

    CompanyDatePrice TargetRatingAnalyst
    uniQure N.V.
    $QURE
    3/11/2026$35.00Neutral → Outperform
    Mizuho
    uniQure N.V.
    $QURE
    3/9/2026$60.00Equal Weight → Overweight
    Wells Fargo
    uniQure N.V.
    $QURE
    3/9/2026$35.00Sector Perform → Outperform
    RBC Capital Mkts
    uniQure N.V.
    $QURE
    3/3/2026$15.00Overweight → Equal Weight
    Wells Fargo
    uniQure N.V.
    $QURE
    3/3/2026$12.00Outperform → Neutral
    Mizuho
    uniQure N.V.
    $QURE
    3/2/2026$11.00Outperform → Sector Perform
    RBC Capital Mkts
    uniQure N.V.
    $QURE
    3/2/2026$9.00Overweight → Neutral
    Cantor Fitzgerald
    uniQure N.V.
    $QURE
    2/24/2026Peer Perform
    Wolfe Research
    More analyst ratings

    $HELE
    $INDV
    $PEGY
    $QURE
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Helen of Troy Reports Fourth Quarter Fiscal 2026 Results

    Consolidated Net Sales Decline of 3.3% GAAP Diluted Loss Per Share of $2.41 Adjusted Diluted EPS(1) of $0.83 Cash Flow from Operations of $111.3 Million; Free Cash Flow(1)(2) of $103.1 Million   Initiates Fiscal 2027 Outlook: Consolidated Net Sales of $1.751-$1.822 Billion GAAP Diluted EPS of $3.57-$4.18; Adjusted Diluted EPS(1) of $3.25-$3.75 Adjusted EBITDA(1) of $190-$197 Million; Free Cash Flow(1)(2) of $85-$100 Million Helen of Troy Limited (NASDAQ:HELE) reported results for the three-month period ended February 28, 2026 and provided its outlook for fiscal 2027. Executive Summary – Fourth Quarter of Fiscal 2026 Compared to Fiscal 2025 Consolidated net sales revenue of $470.0

    4/23/26 6:45:00 AM ET
    $HELE
    Home Furnishings
    Consumer Discretionary

    Survey of Correctional Facility Staff: Monthly Opioid Treatment Shot May Help Reduce Medication Misuse

    RICHMOND, Va., April 16, 2026 (GLOBE NEWSWIRE) -- Indivior PLC (NASDAQ:INDV) today announced results from a national survey published in the Journal of Correctional Health Care showing that correctional leaders identify staffing and coordination gaps as key barriers to reducing diversion of medications for opioid use disorder (MOUD) and recognized long-acting injectable (LAI) buprenorphine as a strategy to help mitigate diversion and improve treatment in jail and prison settings. The cross-sectional survey included responses from 180 correctional professionals across U.S. jail and prison facilities. Among respondents, a strong majority — 88% of those working in jails and 87% in prisons —

    4/16/26 2:30:00 PM ET
    $INDV
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Indivior to Report First Quarter 2026 Financial Results and Host Webcast on April 30th

    RICHMOND, Va., April 09, 2026 (GLOBE NEWSWIRE) -- Indivior Pharmaceuticals, Inc. (NASDAQ:INDV) today announced that it will report its first quarter 2026 financial results on Thursday, April 30, 2026, at 7:00 a.m. U.S. EDT. Following the release of the financial results, Joe Ciaffoni, Chief Executive Officer, and other members of Indivior's leadership team will host a presentation via live webcast at 8:00 a.m. U.S. EDT. Access to the Live Webcast Presentation: The webcast event and materials can be accessed on the "Investors" section of the company's website at www.indivior.com before the event begins. Live webcast link: https://edge.media-server.com/mmc/p/3k7nbxjp Participants may acc

    4/9/26 7:00:00 AM ET
    $INDV
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $HELE
    $INDV
    $PEGY
    $QURE
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Ryan Barbara bought $249 worth of shares (8 units at $31.09), increasing direct ownership by 0.14% to 5,724 units (SEC Form 4)

    4 - Indivior Pharmaceuticals, Inc. (0001625297) (Issuer)

    3/13/26 4:25:33 PM ET
    $INDV
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Director Kingsley Stuart A bought $29,953 worth of shares (940 units at $31.86), increasing direct ownership by 20% to 5,582 units (SEC Form 4)

    4 - Indivior Pharmaceuticals, Inc. (0001625297) (Issuer)

    3/11/26 9:54:36 AM ET
    $INDV
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Director Ryan Barbara bought $1,009 worth of shares (31 units at $32.56), increasing direct ownership by 0.55% to 5,716 units (SEC Form 4)

    4 - Indivior Pharmaceuticals, Inc. (0001625297) (Issuer)

    3/11/26 8:12:31 AM ET
    $INDV
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $HELE
    $INDV
    $PEGY
    $QURE
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Financial Officer Preblick Ryan converted options into 6,302 shares and covered exercise/tax liability with 2,843 shares, increasing direct ownership by 1% to 320,751 units (SEC Form 4)

    4 - Indivior Pharmaceuticals, Inc. (0001625297) (Issuer)

    3/17/26 4:32:18 PM ET
    $INDV
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Director Ryan Barbara bought $249 worth of shares (8 units at $31.09), increasing direct ownership by 0.14% to 5,724 units (SEC Form 4)

    4 - Indivior Pharmaceuticals, Inc. (0001625297) (Issuer)

    3/13/26 4:25:33 PM ET
    $INDV
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Director Kingsley Stuart A bought $29,953 worth of shares (940 units at $31.86), increasing direct ownership by 20% to 5,582 units (SEC Form 4)

    4 - Indivior Pharmaceuticals, Inc. (0001625297) (Issuer)

    3/11/26 9:54:36 AM ET
    $INDV
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $HELE
    $INDV
    $PEGY
    $QURE
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    uniQure upgraded by Mizuho with a new price target

    Mizuho upgraded uniQure from Neutral to Outperform and set a new price target of $35.00

    3/11/26 8:30:07 AM ET
    $QURE
    Biotechnology: Pharmaceutical Preparations
    Health Care

    uniQure upgraded by RBC Capital Mkts with a new price target

    RBC Capital Mkts upgraded uniQure from Sector Perform to Outperform and set a new price target of $35.00

    3/9/26 8:45:00 AM ET
    $QURE
    Biotechnology: Pharmaceutical Preparations
    Health Care

    uniQure upgraded by Wells Fargo with a new price target

    Wells Fargo upgraded uniQure from Equal Weight to Overweight and set a new price target of $60.00

    3/9/26 8:45:00 AM ET
    $QURE
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $HELE
    $INDV
    $PEGY
    $QURE
    SEC Filings

    View All

    SEC Form 10-K filed by Helen of Troy Limited

    10-K - HELEN OF TROY LTD (0000916789) (Filer)

    4/23/26 6:56:18 AM ET
    $HELE
    Home Furnishings
    Consumer Discretionary

    Helen of Troy Limited filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - HELEN OF TROY LTD (0000916789) (Filer)

    4/23/26 6:50:16 AM ET
    $HELE
    Home Furnishings
    Consumer Discretionary

    SEC Form PRE 14A filed by uniQure N.V.

    PRE 14A - uniQure N.V. (0001590560) (Filer)

    4/16/26 5:00:35 PM ET
    $QURE
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $HELE
    $INDV
    $PEGY
    $QURE
    Leadership Updates

    Live Leadership Updates

    View All

    CRH, Carvana and Comfort Systems USA Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600

    NEW YORK, Dec. 5, 2025 /PRNewswire/ -- S&P Dow Jones Indices ("S&P DJI") will make the following changes to the S&P 500, S&P MidCap 400, and S&P SmallCap 600 indices effective prior to the open of trading on Monday, December 22, to coincide with the quarterly rebalance. The changes ensure that each index is more representative of its market capitalization range. The companies being removed from the S&P SmallCap 600 are no longer representative of the small-cap market space.  Following is a summary of the changes that will take place prior to the open of trading on the effective date: Effective Date Index Name Action Company Name Ticker GICS Sector Dec 22, 2025  S&P 500 Addition CRH CRH Mat

    12/5/25 5:49:00 PM ET
    $ASIX
    $BAH
    $BWA
    Major Chemicals
    Industrials
    Professional Services
    Consumer Discretionary

    Soligenix Announces Appointment of Former White House Economic Adviser Tomas J. Philipson, PhD as Strategic Advisor

    Contributing Broad Business and Government Affairs Expertise and Network PRINCETON, N.J., Sept. 23, 2025 /PRNewswire/ -- Soligenix, Inc. (NASDAQ:SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today the appointment of Tomas J. Philipson, PhD as a Strategic Advisor. Dr. Philipson is considered an expert in United States (U.S.) economic policy, particularly health care policy, and frequently appears on major media outlets, including F

    9/23/25 7:30:00 AM ET
    $SNGX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    OXO Announces 2025 Chefs in Residence: Fariyal Abdullahi and Danielle Sepsy Join for a New Season Inspired by Bold Flavors and Heritage

    NEW YORK, Sept. 2, 2025 /PRNewswire/ -- OXO, an award-winning consumer brand from the Home & Outdoor business segment of Helen of Troy Limited (NASDAQ:HELE), kicks off the fifth year of its acclaimed Chefs in Residence program by welcoming two dynamic new culinary voices: Executive Chef at Hav & Mar, Fariyal Abdullahi and Founder of The Hungry Gnome, Danielle Sepsy. Now entering its fifth year, the OXO Chefs in Residence program continues to evolve with a renewed focus on emotional storytelling and globally inspired cooking. This year's theme, Cook the Mood, taps into the deep

    9/2/25 11:04:00 AM ET
    $HELE
    Home Furnishings
    Consumer Discretionary

    $HELE
    $INDV
    $PEGY
    $QURE
    Financials

    Live finance-specific insights

    View All

    Indivior to Report First Quarter 2026 Financial Results and Host Webcast on April 30th

    RICHMOND, Va., April 09, 2026 (GLOBE NEWSWIRE) -- Indivior Pharmaceuticals, Inc. (NASDAQ:INDV) today announced that it will report its first quarter 2026 financial results on Thursday, April 30, 2026, at 7:00 a.m. U.S. EDT. Following the release of the financial results, Joe Ciaffoni, Chief Executive Officer, and other members of Indivior's leadership team will host a presentation via live webcast at 8:00 a.m. U.S. EDT. Access to the Live Webcast Presentation: The webcast event and materials can be accessed on the "Investors" section of the company's website at www.indivior.com before the event begins. Live webcast link: https://edge.media-server.com/mmc/p/3k7nbxjp Participants may acc

    4/9/26 7:00:00 AM ET
    $INDV
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Helen of Troy Limited Announces Earnings Release Date, Conference Call, and Webcast for Fourth Quarter and Fiscal Year 2026 Results

    Helen of Troy Limited (NASDAQ:HELE), designer, developer, and worldwide marketer of branded consumer home, outdoor, beauty, and wellness products, today announced that the Company will release its fourth quarter and fiscal year 2026 results before the stock market opens on Thursday, April 23, 2026. The Company will conduct a conference call to discuss its fourth quarter and fiscal year 2026 results on the same day, Thursday, April 23, 2026, at 9:00 a.m. Eastern Time. The conference call will be hosted by G. Scott Uzzell, Chief Executive Officer, and Brian Grass, Chief Financial Officer. Institutional investors and analysts interested in participating in the call are invited to dial (877)

    4/6/26 4:05:00 PM ET
    $HELE
    Home Furnishings
    Consumer Discretionary

    uniQure Announces 2025 Financial Results and Provides Recent Company Updates

    ~ Held Type A meeting with FDA to discuss AMT-130 for Huntington's disease; Company evaluating Phase III development considerations and plans to request follow-up Type B meeting in the second quarter of 2026 ~ ~ Completed enrollment of the first cohort in the Phase I/IIa study of AMT-260 in refractory mesial temporal lobe epilepsy, with additional clinical data expected in the first half of 2026 ~ ~ Presented updated Phase I/II data from AMT-191 in Fabry disease showing durable, dose-dependent increases in α-Gal A enzyme activity ~ ~ Cash, cash equivalents and current investment securities of approximately $622.5 million as of December 31, 2025 expected to fund operations into the second

    3/2/26 7:05:00 AM ET
    $QURE
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $HELE
    $INDV
    $PEGY
    $QURE
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Indivior PLC

    SC 13G - INDIVIOR PLC (0001625297) (Subject)

    11/15/24 6:03:54 PM ET
    $INDV
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by Indivior PLC

    SC 13G/A - INDIVIOR PLC (0001625297) (Subject)

    11/14/24 5:00:25 PM ET
    $INDV
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by Helen of Troy Limited

    SC 13G/A - HELEN OF TROY LTD (0000916789) (Subject)

    11/14/24 3:53:05 PM ET
    $HELE
    Home Furnishings
    Consumer Discretionary